Literature DB >> 10234432

Partial regression of advanced cyclosporin-induced gingival hyperplasia after treatment with azithromycin. A case report.

M Nowicki1, F Kokot, A Wiecek.   

Abstract

Gingival hyperplasia is a well recognised complication of cyclosporin A therapy. Although its pathogenesis is still debated in several recent reports a second generation macrolide antibiotic-azithromycin induced partial or even complete regression of hyperplasia. We present a patient after kidney transplantation treated with cyclosporin who developed very advanced gigival overgrowth (stage 3+). The patient received a 3-day treatment with azithromycin which was repeated after 3 months. The first course of the drug caused a partial regression of gingival hyperplasia during following months but the repeated treatment did not provide a further regression of the changes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10234432

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  4 in total

1.  Management of Cyclosporine and Nifedipine-Induced Gingival Hyperplasia.

Authors:  Cüneyt Asim Aral; Erhan Dilber; Kübra Aral; Yagmur Sarica; Oya Nermin Sivrikoz
Journal:  J Clin Diagn Res       Date:  2015-12-01

Review 2.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

3.  Efficacy of AZM therapy in patients with gingival overgrowth induced by Cyclosporine A: a systematic review.

Authors:  Marco Clementini; Gianluca Vittorini; Alessandro Crea; Maria Rosaria Gualano; Ludovica Antonella Macrì; Giorgio Deli; Giuseppe La Torre
Journal:  BMC Oral Health       Date:  2008-12-16       Impact factor: 2.757

Review 4.  Drug-induced gingival overgrowth: A critical insight into case reports from over two decades.

Authors:  Pramod Samudrala; Vijay Kumar Chava; Tanguturi Sri Chandana; Rachakonda Suresh
Journal:  J Indian Soc Periodontol       Date:  2016 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.